Immuneering Financial Statements From 2010 to 2026
| IMRX Stock | USD 4.73 3.60 43.22% |
Check Immuneering Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immuneering Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Immuneering financial statements analysis is a perfect complement when working with Immuneering Corp Valuation or Volatility modules.
Immuneering | Build AI portfolio with Immuneering Stock |
Immuneering Corp Company Current Valuation Analysis
Immuneering Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Immuneering Corp Current Valuation | 203.16 M |
Most of Immuneering Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immuneering Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Immuneering Corp has a Current Valuation of 203.16 M. This is 98.59% lower than that of the Biotechnology sector and 95.63% lower than that of the Health Care industry. The current valuation for all United States stocks is 98.78% higher than that of the company.
Immuneering Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immuneering Corp's current stock value. Our valuation model uses many indicators to compare Immuneering Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immuneering Corp competition to find correlations between indicators driving Immuneering Corp's intrinsic value. More Info.Immuneering Corp is rated fifth overall in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immuneering Corp's earnings, one of the primary drivers of an investment's value.About Immuneering Corp Financial Statements
Immuneering Corp investors use historical fundamental indicators, such as Immuneering Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immuneering Corp. Please read more on our technical analysis and fundamental analysis pages.
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited. Immuneering Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.